JPM Deep Coverage Review — Analysis as of August 10, 2026
JPMorgan’s franchise remains exceptional, while a record multiple and incomplete credit visibility raise the proof bar.
CAMS Research Desk
MOH Research Note — The Cost Ratio Test
Molina’s cash flow supports the recovery case, while Marketplace losses and the October medical-cost test keep conviction limited.
MOH Deep Coverage Review — Analysis as of August 10, 2026
Molina’s cash flow and long-term structure support recovery, but Marketplace losses and Medicaid policy pressure leave little room for error.
HBAN Research Note — The Reserve Test
HBAN remains profitable, but falling CRE reserve coverage and faster nonaccrual growth make the October credit disclosure the central evidence test.
HBAN Deep Coverage Review — Analysis as of August 10, 2026
HBAN’s sound earnings base is offset by declining CRE reserve coverage and nonaccrual growth that is outpacing the underlying commercial loan book.
FITBPA Research Note — Credit Holds, Rates Decide
Fifth Third credit remains sound, but FITBPA closed near a fresh one-year low as long Treasury yields kept pressure on perpetual preferreds.
FITBPA Deep Coverage Review — Analysis as of August 10, 2026
FITBPA offers sound issuer credit and a 6.66% current yield, while a fresh one-year low shows that perpetual duration still controls valuation.
Desk Note — Fed Signals More Than One Hike · Aug 10
An explicit multi-hike call raises the discount-rate bar across growth, financial, and defensive exposures.
MS Research Note — Strong Quarter, Full Price
Record wealth flows and a 26.6% return support the franchise case, but the valuation already assumes durable execution.
MS Deep Coverage Review — Analysis as of August 7, 2026
Morgan Stanley’s wealth engine is producing exceptional returns, while full valuation and AI-credit strain raise the proof bar.